Anna O. Protopopova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna O. Protopopova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Nataliya Yu. Abramycheva
Research Center of Neurology
4 shared publications - Sergey Nikolaevich Illarioshkin
Russian Center of Neurology and Neurosciences; Russian University of Medicine, Ministry of Health of Russia
4 shared publications - Ekaterina Yu. Fedotova
Research Center of Neurology
3 shared publications - Evgenii P. Nuzhnyi
Research Center of Neurology
2 shared publications - Arina R. Protsenko
Russian Center of Neurology and Neurosciences
1 shared publication - I.A. Chkhartishvili
Research Center of Neurology, Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 15 March 2025
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 19 (1) , 43-52
Polymorphisms in the SNCA gene and the risk of synucleopathy
Introduction. Synucleinopathies are mostly sporadic and multifactorial neurodegenerative disorders, which determines the involvement of various risk factors in their development. The polymorphic variants of the SNCA gene are considered as one of the predisposing genetic factors. Study aim: to evaluate the effect of the 16 single nucleotide polymorphisms (SNP) located in various regulatory regions of the SNCA gene on the risk of developing three main forms of synucleinopathy — PD, DBL, and MSA — in Russian cohort of patients. Materials and methods. The study included 73 PD patients, 46 MSA patients, 10 DLB patients, and 62 healthy volunteers. Genotyping of 16 SNPs of the SNCA gene was performed by direct Sanger sequencing on a capillary genetic analyzer. The Benjamini–Hochberg procedure was applied for multiple pairwise comparisons. Results. A comparative case-control study showed that only one (rs11931074) of the 16 SNP analyzed was associated with PD: the minor T allele, located in the 3’-UTR region of the SNCA gene, increased the risk of PD (OR = 5.19; p 0.05 (Benjamini–Hochberg adjusted p = 0.6)). An association with MSA was found for 11 of 16 SNP. The minor allele of 5 SNP (rs2619364, rs2619363, rs2619362, rs2619361, rs181489) reduced the risk of the disease, while for 6 SNP (rs7687945, rs2301134, rs2301135, rs3756063, rs2736990, rs11931074) increased the risk. The Benjamini–Hochberg procedure neutralized the significance of only one of these associations (rs181489). Conclusion. This study is the first to genotype a large group of polymorphisms located in various regulatory regions of the SNCA gene and to establish significant associations with the risk of developing one of the forms of synucleinopathies, MSA, in the Russian population.
- 15 March 2025
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 19 (1) , 43-52
Open AccessPolymorphisms in the SNCA gene and the risk of synucleopathy
Introduction. Synucleinopathies are mostly sporadic and multifactorial neurodegenerative disorders, which determines the involvement of various risk factors in their development. The polymorphic variants of the SNCA gene are considered as one of the predisposing genetic factors. Study aim: to evaluate the effect of the 16 single nucleotide polymorphisms (SNP) located in various regulatory regions of the SNCA gene on the risk of developing three main forms of synucleinopathy — PD, DBL, and MSA — in Russian cohort of patients. Materials and methods. The study included 73 PD patients, 46 MSA patients, 10 DLB patients, and 62 healthy volunteers. Genotyping of 16 SNPs of the SNCA gene was performed by direct Sanger sequencing on a capillary genetic analyzer. The Benjamini–Hochberg procedure was applied for multiple pairwise comparisons. Results. A comparative case-control study showed that only one (rs11931074) of the 16 SNP analyzed was associated with PD: the minor T allele, located in the 3’-UTR region of the SNCA gene, increased the risk of PD (OR = 5.19; p 0.05 (Benjamini–Hochberg adjusted p = 0.6)). An association with MSA was found for 11 of 16 SNP. The minor allele of 5 SNP (rs2619364, rs2619363, rs2619362, rs2619361, rs181489) reduced the risk of the disease, while for 6 SNP (rs7687945, rs2301134, rs2301135, rs3756063, rs2736990, rs11931074) increased the risk. The Benjamini–Hochberg procedure neutralized the significance of only one of these associations (rs181489). Conclusion. This study is the first to genotype a large group of polymorphisms located in various regulatory regions of the SNCA gene and to establish significant associations with the risk of developing one of the forms of synucleinopathies, MSA, in the Russian population.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (8) , 32-38
Rare forms of autosomal recessive spinocerebellar ataxia associated with mutations in the ANO10 (ATX-ANO10) and SYNE1 (ATX-SYNE1) genes
Objective. To analyze clinical and genetic characteristics of patients with the verified rare forms of autosomal recessive spinocerebellar ataxias, ATX-ANO10 and ATX-SYNE1. Material and methods. Six unrelated patients with established diagnoses were examined: 4 patients with ATX-ANO10 and 2 patients with ATX-SYNE1. Brain MRI and nerve conduction study were performed. To screen for cognitive impairment, the scale for the Assessment and Rating of Ataxia (SARA), and the Montreal Cognitive Assessment Scale (MoCA) were used. Mutation screening included panel sequencing on the Illumina MiSeq platform. Results. Six variants were found in the ANO10 gene: the previously described pathogenic nonsense mutations c.G1025A (p.W342X) and c.C1244G (p.S415X), as well as novel probably pathogenic variants c.1477-2A>G and c.G101T (p.W34L) and missense mutations c.A110C (p.N37T) and c.T104C (p.L35P) of undetermined significance. A novel nonsense mutation c.C8911T (p.Q2971X) and a previously described pathogenic variant c.C4939T (p.Q1647X) were found in the SYNE1 gene. The clinical presentation of the ATX-ANO10 and ATX-SYNE1 was typical presenting with slowly progressive cerebellar ataxia with pyramidal signs, with young onset and cerebellar atrophy according to brain MRI study. Conclusion. We provided first-ever data on clinical features and mutation spectrum In Russian patients with ATX-ANO10 and ATX-SYNE1. The phenotype of these ataxias is nonspecific, so the method of choice for molecular diagnostics is massive parallel sequencing.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (8) , 32-38
Rare forms of autosomal recessive spinocerebellar ataxia associated with mutations in the ANO10 (ATX-ANO10) and SYNE1 (ATX-SYNE1) genes
Objective. To analyze clinical and genetic characteristics of patients with the verified rare forms of autosomal recessive spinocerebellar ataxias, ATX-ANO10 and ATX-SYNE1. Material and methods. Six unrelated patients with established diagnoses were examined: 4 patients with ATX-ANO10 and 2 patients with ATX-SYNE1. Brain MRI and nerve conduction study were performed. To screen for cognitive impairment, the scale for the Assessment and Rating of Ataxia (SARA), and the Montreal Cognitive Assessment Scale (MoCA) were used. Mutation screening included panel sequencing on the Illumina MiSeq platform. Results. Six variants were found in the ANO10 gene: the previously described pathogenic nonsense mutations c.G1025A (p.W342X) and c.C1244G (p.S415X), as well as novel probably pathogenic variants c.1477-2A>G and c.G101T (p.W34L) and missense mutations c.A110C (p.N37T) and c.T104C (p.L35P) of undetermined significance. A novel nonsense mutation c.C8911T (p.Q2971X) and a previously described pathogenic variant c.C4939T (p.Q1647X) were found in the SYNE1 gene. The clinical presentation of the ATX-ANO10 and ATX-SYNE1 was typical presenting with slowly progressive cerebellar ataxia with pyramidal signs, with young onset and cerebellar atrophy according to brain MRI study. Conclusion. We provided first-ever data on clinical features and mutation spectrum In Russian patients with ATX-ANO10 and ATX-SYNE1. The phenotype of these ataxias is nonspecific, so the method of choice for molecular diagnostics is massive parallel sequencing.
- Open Access
- 30 April 2023
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 15 (2) , 63-67
Rapidly progressive dementia with early onset associated with the I143T mutation in the PSEN1 gene: a clinical case in a family from Russia
Rapidly progressive dementias are a rare group of cognitive disorders that primarily require the exclusion of a large number of potentially reversible causes. Prion diseases are frequent in this group of disorders. Some hereditary forms of Alzheimer's disease can also be aggressive, with onset at a young age and autosomal dominant inheritance in the family. The article presents the first case report of a patient with a verified Ile143Thr mutation in the PSEN1 gene in a Russian family with a phenotype similar to the hereditary form of Creutzfeldt–Jakob disease. The specific features of the disease, diagnostic methods, and possible pathogenesis of the development are discussed.
- 30 April 2023
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 15 (2) , 63-67
Open AccessRapidly progressive dementia with early onset associated with the I143T mutation in the PSEN1 gene: a clinical case in a family from Russia
Rapidly progressive dementias are a rare group of cognitive disorders that primarily require the exclusion of a large number of potentially reversible causes. Prion diseases are frequent in this group of disorders. Some hereditary forms of Alzheimer's disease can also be aggressive, with onset at a young age and autosomal dominant inheritance in the family. The article presents the first case report of a patient with a verified Ile143Thr mutation in the PSEN1 gene in a Russian family with a phenotype similar to the hereditary form of Creutzfeldt–Jakob disease. The specific features of the disease, diagnostic methods, and possible pathogenesis of the development are discussed.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (8) , 106-111
Spinocerebellar ataxia type 8 in Russian patients
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить частоту встречаемости спиноцеребеллярной атаксии 8-го типа (СЦА8) у пациентов с прогрессирующими мозжечковыми атаксиями, описать клинические особенности фенотипа у пациентов с СЦА8. МАТЕРИАЛ И МЕТОДЫ Генотипирование CTA/CTG-повторов в гене ATXN8OS проведено 411 пациентам с дегенеративными атаксиями методом фрагментного анализа. Предварительно были исключены СЦА 1, 2, 3 и 6-го типов, атаксия Фридрейха. Всем пациентам выполнена МРТ головного мозга, оценка по шкале для обследования и оценки атаксии (SARA), для скрининга когнитивных нарушений использовали Монреальскую шкалу оценки когнитивных функций. РЕЗУЛЬТАТЫ Выявлены 6 (1,5%) пациентов с СЦА8 — носители экспансии в гене ATXN8OS (91—152 CTA/CTG-повторов). Все случаи были спорадическими. Возраст дебюта варьировал от 14 до 42 лет. У всех пациентов отмечалась медленно прогрессирующая мозжечковая атаксия, глазодвигательные нарушения, дизартрия, пирамидный синдром, у двух больных — когнитивные нарушения. У одной пациентки клиническая картина соответствовала мультисистемной атрофии мозжечкового типа (атаксия, ортостатическая гипотензия, атрофия мозжечка и ствола мозга). МРТ головного мозга у всех пациентов выявила атрофию мозжечка. ЗАКЛЮЧЕНИЕ СЦА8 является редкой формой аутосомно-доминантной атаксии с преобладанием классического фенотипа. Все выявленные случаи СЦА8 были спорадическими, что необходимо учитывать при планировании генетического тестирования у пациентов с СЦА.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (8) , 106-111
Spinocerebellar ataxia type 8 in Russian patients
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить частоту встречаемости спиноцеребеллярной атаксии 8-го типа (СЦА8) у пациентов с прогрессирующими мозжечковыми атаксиями, описать клинические особенности фенотипа у пациентов с СЦА8. МАТЕРИАЛ И МЕТОДЫ Генотипирование CTA/CTG-повторов в гене ATXN8OS проведено 411 пациентам с дегенеративными атаксиями методом фрагментного анализа. Предварительно были исключены СЦА 1, 2, 3 и 6-го типов, атаксия Фридрейха. Всем пациентам выполнена МРТ головного мозга, оценка по шкале для обследования и оценки атаксии (SARA), для скрининга когнитивных нарушений использовали Монреальскую шкалу оценки когнитивных функций. РЕЗУЛЬТАТЫ Выявлены 6 (1,5%) пациентов с СЦА8 — носители экспансии в гене ATXN8OS (91—152 CTA/CTG-повторов). Все случаи были спорадическими. Возраст дебюта варьировал от 14 до 42 лет. У всех пациентов отмечалась медленно прогрессирующая мозжечковая атаксия, глазодвигательные нарушения, дизартрия, пирамидный синдром, у двух больных — когнитивные нарушения. У одной пациентки клиническая картина соответствовала мультисистемной атрофии мозжечкового типа (атаксия, ортостатическая гипотензия, атрофия мозжечка и ствола мозга). МРТ головного мозга у всех пациентов выявила атрофию мозжечка. ЗАКЛЮЧЕНИЕ СЦА8 является редкой формой аутосомно-доминантной атаксии с преобладанием классического фенотипа. Все выявленные случаи СЦА8 были спорадическими, что необходимо учитывать при планировании генетического тестирования у пациентов с СЦА.